Note: The citation metrics presented here have been sourced from Semantic Scholar and OpenAlex.
Explore these studies to deepen your understanding of the subject.
Prolonged response to first-generation tyrosine kinase inhibitor in a metastatic non-small cell lung cancer harbouring complex G719X and S768I mutations: A case report from Vietnam and literature review
K. H. Do, D. T. Le, et al.
Entrectinib in ROS1-positive advanced non-small cell lung cancer: the phase 2/3 BFAST trial
S. Peters, S. M. Gadgeel, et al.
Association between pretreatment emotional distress and immune checkpoint inhibitor response in non-small-cell lung cancer
Y. Zeng, C. Hu, et al.
Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial
B. Besse, E. Pons-tostivint, et al.
